114
Views
7
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLESClinical Translational Therapeutics

Identification of Oral Cancer Cell-Induced Changes in Gene Expression Profile of Lymphatic Endothelial Cell

, , , &
Pages 1002-1007 | Published online: 11 Jun 2009

REFERENCES

  • Shayan R., Achen M. G., Stacker S. A. Lymphatic vessels in cancer metastasis: bridging the gaps. Carcinogenesis 2006; 27: 1729–38
  • Farnsworth R. H., Achen M. G., Stacker S. A. Lymphatic endothelium: an important interactive surface for malignant cells. Pulm Pharmacol Ther 2006; 19: 51–60
  • Irjala H., Alanen K., Grénman R., Heikkilä P., Joensuu H., Jalkanen S. Mannose receptor (MR) and common lymphatic endothelial and vascular endothelial receptor (CLEVER)-1 direct the binding of cancer cells to the lymph vessel endothelium. Cancer Res 2003; 63: 4671–6
  • Jackson D. G., Prevo R., Clasper S., Banerji S. LYVE-1, the lymphatic system and tumor lymphangiogenesis. Trends Immunol 2001; 22: 317–21
  • Ohl L., Mohaupt M., Czeloth N., Hintzen G., Kiafard Z., Zwirner J. CCR7 governs skin dendritic cell migration under inflammatory and steady-state conditions. Immunity 2004; 21: 279–88
  • Muller A., Homey B., Soto H., Ge N., Catron D., Buchanan M. E. Involvement of chemokine receptors in breast cancer metastasis. Nature 2001; 410: 50–6
  • Allport J. R., Weissleder R. Murine Lewis lung carcinoma-derived endothelium expresses markers of endothelial activation and requires tumor-specific extracellular matrix in vitro. Neoplasia 2003; 5: 205–17
  • Bussolati B., Deambrosis I., Russo S., Deregibus M. C., Camussi G. Altered angiogenesis and survival in human tumor-derived endothelial cells. FASEB J 2003; 17: 1159–61
  • St Croix B., Rago C., Velculescu V., Traverso G., Romans K. E., Montgomery E. Genes expressed in human tumor endothelium. Science 2000; 289: 1197–202
  • Karpanen T., Alitalo K. Lymphatic vessels as targets of tumor therapy?. J Exp Med 2001; 194: F37–42
  • Laakkonen P., Porkka K., Hoffman J. A., Ruoslahti E. A tumor-homing peptide with a targeting specificity related to lymphatic vessels. Nat Med 2002; 8: 751–5
  • Ikuta T., Ariga H., Matsumoto K. Extracellular matrix tenascin-X in combination with vascular endothelial growth factor B enhances endothelial cell proliferation. Genes Cells 2000; 5(11)913–27
  • van 't Veer L. J., Dai H., van de Vijver M. J., He Y. D., Hart A. A., Mao M. Gene expression profiling predicts clinical outcome of breast cancer. Nature 2002; 415: 530–6
  • O'Donnell R. K., Kupferman M., Wei S. J., Singhal S., Weber R., O'Malley B. Gene expression signature predicts lymphatic metastasis in squamous cell carcinoma of the oral cavity. Oncogene 2005; 24: 1244–51
  • Beasley N. J., Prevo R., Banerji S., Leek R. D., Moore J., van Trappen P. Intratumoral lymphangiogenesis and lymph node metastasis in head and neck cancer. Cancer Res 2002; 62: 1315–20
  • Kyzas P. A., Geleff S., Batistatou A., Agnantis N. J., Stefanou D. Evidence for lymphangiogenesis and its prognostic implications in head and neck squamous cell carcinoma. J Pathol 2005; 206: 170–7
  • Kyzas P. A., Stefanou D., Batistatou A., Agnantis N. J., Nakanishi Y., Hirohashi S. Dysadherin expression in head and neck squamous cell carcinoma: association with lymphangiogenesis and prognostic significance. Am J Surg Pathol 2006; 30(2)185–93
  • Yu H., Zhou H. Z., Wang C. M., Gu X. M., Pan B. R. Effect of hepatoma H22 on lymphatic endothelium in vitro. World J Gastroenterol 2004; 10: 3428–32
  • Irigoyen M., Ansó E., Martínez E., Garayoa M., Martínez-Irujo J. J., Rouzaut A. Hypoxia alters the adhesive properties of lymphatic endothelial cells. A transcriptional and functional study. Biochim Biophys Acta 2007; 1773: 880–90
  • Condeelis J., Pollard J. W. Macrophages: obligate partners for tumor cell migration, invasion, and metastasis. Cell 2006; 124: 263–6
  • Chambers A. F., Groom A. C., MacDonald I. C. Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer 2002; 2: 563–72
  • Pepper M. S., Skobe M. Lymphatic endothelium: morphological, molecular and functional properties. J Cell Biol 2003; 163: 209–13
  • Hirakawa S., Hong Y. K., Harvey N., Schacht V., Matsuda K., Libermann T. Identification of vascular lineage-specific genes by transcriptional profiling of isolated blood vascular and lymphatic endothelial cells. Am J Pathol 2003; 162: 575–86
  • Chang L. K., Garcia-Cardeña G., Farnebo F., Fannon M., Chen E. J., Butterfield C. Dose-dependent response of FGF-2 for lymphangiogenesis. Proc Natl Acad Sci U S A 2004; 101: 11658–63
  • Tammela T., Enholm B., Alitalo K., Paavonen K. The biology of vascular endothelial growth factors. Cardiovasc Res 2005; 65: 550–63
  • Nakamura Y., Yasuoka H., Tsujimoto M., Imabun S., Nakahara M., Nakao K. Lymph vessel density correlates with nodal status, VEGF-C expression, and prognosis in breast cancer. Breast Cancer Res Treat 2005; 91: 125–32
  • Sedivy R., Beck-Mannagetta J., Haverkampf C., Battistutti W., Hönigschnabl S. Expression of vascular endothelial growth factor-C correlates with the lymphatic microvessel density and the nodal status in oral squamous cell cancer. J Oral Pathol Med 2003; 32: 455–60
  • Murga M., Fernandez-Capetillo O., Tosato G. Neuropilin-1 regulates attachment in human endothelial cells independently of vascular endothelial growth factor receptor-2. Blood 2005; 105: 1992–9
  • Becker P. M., Waltenberger J., Yachechko R., Mirzapoiazova T., Sham J. S., Lee C. G. Neuropilin-1 regulates vascular endothelial growth factor-mediated endothelial permeability. Circ Res 2005; 96: 1257–65
  • Tas F., Duranyildiz D., Oguz H., Camlica H., Yasasever V., Topuz E. Circulating serum levels of angiogenic factors and vascular endothelial growth factor receptors 1 and 2 in melanoma patients. Melanoma Res 2006; 16: 405–11
  • Le Jan S., Amy C., Cazes A., Monnot C., Lamand N., Favier J. Angiopoietin-like 4 is a proangiogenic factor produced during ischemia and in conventional renal cell carcinoma. Am J Pathol 2003; 162: 1521–8
  • Han S., Ritzenthaler J. D., Sitaraman S. V., Roman J. Fibronectin increases matrix metalloproteinase 9 expression through activation of c-Fos via extracellular-regulated kinase and phosphatidylinositol 3-kinase pathways in human lung carcinoma cells. J Biol Chem 2006; 281: 29614–24

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.